Vaxtex Cotfab Q3 FY26 PAT jumps to Rs 394.61 lakh, revenue at Rs 887.99 lakh

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

VCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.9%Reaction day

₹2.06

prior close

₹2.14

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+4.4% vs market

Other Textile Products peers, median of 165sector+0.0%+3.9% vs sector

On the reaction day the stock moved 4.4 pts more than Nifty Microcap 250 and 3.9 pts more than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.9-0.5+4.4+0.0+3.9

Next day

+7.3-2.0+9.2-0.1+7.4

+6.8-2.7+9.5-1.1+7.9

+1.5-1.7+3.2-1.0+2.5

+3.9-1.4+5.3-1.6+5.5

+5.8-2.8+8.7-2.4+8.2

+5.8-2.8+8.7-2.7+8.5

15d

-5.8-8.4+2.6-7.8+2.0

-22.3-9.1-13.2-8.9-13.4

-16.0-4.0-12.0-6.8-9.2

-29.1+2.6-31.8-3.8-25.3

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vaxtex Cotfab reported Q3 FY26 revenue of Rs 887.99 lakh versus Rs 228.65 lakh in the previous quarter. Nine month revenue stood at Rs 1,116.64 lakh compared to nil in the year ago period. Net profit for Q3 was Rs 394.61 lakh, taking nine month profit to Rs 473.70 lakh compared to a loss of Rs 43.24 lakh last year. EPS for the quarter was Rs 0.215. Statutory auditor SSRV and Associates issued a clean limited review report with no qualifications.

Likely market impact

Sharp revenue and profit turnaround from prior year loss. Watch whether growth sustains in coming quarters as base effect normalises.